Winchygn Liu
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
RAS signaling at the crossroads of radioresistance and tumor immunity.
Journal: Journal for immunotherapy of cancer
Published: June 29, 2026
Low-dose radiotherapy enhances the efficacy of PD-L1 blockade and induces the abscopal effect.
Journal: Journal for immunotherapy of cancer
Published: May 29, 2025
Non-homogenous intratumor ionizing radiation doses synergize with PD1 and CXCR2 blockade.
Journal: Nature communications
Published: October 11, 2023
Optimal dosing regimen of CD73 blockade improves tumor response to radiotherapy through iCOS downregulation.
Journal: Journal for immunotherapy of cancer
Published: May 16, 2023
KRASG12C inhibition using MRTX1257: a novel radio-sensitizing partner.
Journal: Journal of translational medicine
Published: March 11, 2023
TGFβ receptor inhibition unleashes interferon-β production by tumor-associated macrophages and enhances radiotherapy efficacy.
Journal: Journal for immunotherapy of cancer
Published: February 25, 2022
Dual oxidase 1 limits the IFNγ-associated antitumor effect of macrophages.
Journal: Journal for immunotherapy of cancer
Published: May 14, 2020
Differential therapeutic effects of PARP and ATR inhibition combined with radiotherapy in the treatment of subcutaneous versus orthotopic lung tumour models.
Journal: British journal of cancer
Published: August 15, 2019
Preventing Radiation-Induced Injury by Topical Application of an Amifostine Metabolite-Loaded Thermogel.
Journal: International journal of radiation oncology, biology, physics
Published: January 14, 2019
The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy.
Journal: Molecular cancer therapeutics
Published: February 02, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026